• Home
  • Congress & Events
  • ECP 2023
  • Comparison of data from two commercially available tissue-based comprehensive genomic profiling (CGP) solutions using AMP/ASCO/CAP guidelines and ESMO ESCAT

ECP 2023

Sep 09 - Sep 13, 2023 | Dublin, Ireland / Virtual (Hybrid)

Share this page

Close Tooltip
Copy Link Tooltip

Copy page URL

Comparison of data from two commercially available tissue-based comprehensive genomic profiling (CGP) solutions using AMP/ASCO/CAP guidelines and ESMO ESCAT

Authors Wieland T, Hertel K, Hiemenz M, Fuhlbrück F, Oughton J, Schlecht U, Cantone M, Langer S, Sorensen H, Gonzalez de Castro D, Messina C and Adams H-P

Published date09 September, 2023

This study compared differences in data generated by the AVENIO Tumor Tissue CGP Kit and the TruSight Oncology 500 (TSO) assay - two commercially available pan-cancer solutions. Potential clinical implications of the data generated by both products is presented. Variant calls were acquired using manufacturer-provided software; key variant annotation outputs were variant tiers and ESMO Scale for Clinical Actionability of molecular Targets (ESCAT) guideline inclusion per tumour type. Differences in the detection of tumour mutational burden and ESCAT biomarkers, including copy number alterations, were identified.

Download Current View

Welcome to Medically

The Roche Science Hub

This website is a non-promotional global resource intended to facilitate transparent scientific exchange regarding developments in medical research, diagnostics, and disease management. It is intended for healthcare professionals.

Not a healthcare professional? Browse:

This global website is intended for healthcare professionals outside the UK, US, Canada and Australia. The content on this website may include scientific information about experimental or investigational compounds, indications and services that are not approved or valid in your jurisdiction. Registration status and prescribing information of medicinal products may differ between countries. Please refer to local product information for any medicinal products mentioned on this website. Information available on this website does not constitute professional medical advice, and Roche and Genentech accept no responsibility for access to or use of the same.

You are Leaving Medically

By following this link, you are leaving Roche Website and entering a site that is not owned or controlled by Roche. Roche does not take any responsibility for acces to or use of this website, nor for any content therein.

You are Leaving the Global Medically Site

By following this link, you are being redirected to another Roche page.